In a study published in NEJM Catalyst, Mayo Clinic researchers have demonstrated that chemotherapy can be safely delivered in ...

Objective Studies of dermatomyositis (DM) are frequently limited to single-centre cohorts. We used two large nationally representative US cohorts to conduct a descriptive epidemiological study of the ...

Vyepti is the only migraine preventive given by intravenous infusion on a quarterly schedule, which is why patients often ask how much it costs. The answer depends on the drug price per vial, the dose ...

(Editor’s note: The third in a series of articles leading up to the Sept. 27 Walk to End Alzheimer’s at the Cleveland-Bradley Greenway Park.) The Alzheimer’s Association continues to look for new ...

– Vertex to host investor webcast tonight, June 20, 2025, at 7:15 p.m. CT / 8:15 p.m. ET – BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous ...

Thanks for your patience. Good evening, everyone. My name is Susie Lisa, and I'm the Senior Vice President of Investor Relations for Vertex Pharmaceuticals. Thank you so very much for those of you ...

Background Subcutaneous (SC) administration is the preferred parenteral opioid route in palliative care, while intravenous infusion may allow faster titration. Comparative evidence remains limited.

If there's something we have learnt in the past decade, it is that wellness trends and gadgets have no end, and with each passing day, different companies come up with gadgets that have claims we ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 1 diabetes and recurrent severe ...

Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in the US alone. This case series provides initial insight into the safety and ...